{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:17:39Z","timestamp":1791310659502,"version":"4.3.1"},"reference-count":58,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion Clinique et Biologique"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.tracli.2013.02.005","type":"journal-article","created":{"date-parts":[[2013,4,16]],"date-time":"2013-04-16T22:40:22Z","timestamp":1366152022000},"page":"47-54","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Transfusion de plasma\u00a0: produits\u2013indications"],"prefix":"10.1016","volume":"20","author":[{"given":"R.","family":"Djoudi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tracli.2013.02.005_bib0005","unstructured":"Rapport activit\u00e9 de l\u2019EFS. Ann\u00e9e 2011. http:\/\/www.dondusang.net\/rewrite\/article\/4900\/l-efs\/publications\/feuilletez-en-ligne-le-rapport-d-activite-2011-de-l-efs.htm?idRubrique=790."},{"key":"10.1016\/j.tracli.2013.02.005_bib0010","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.0958-7578.2004.00505.x","article-title":"Improvement in fresh frozen plasma transfusion practice: results of an outcome audit","volume":"14","author":"Kakkar","year":"2004","journal-title":"Transfusion Med"},{"key":"10.1016\/j.tracli.2013.02.005_bib0015","unstructured":"Arr\u00eat\u00e9 du 13\u00a0juillet 2011\u00a0abrogeant l\u2019arr\u00eat\u00e9 du 3\u00a0d\u00e9cembre 1991\u00a0relatif \u00e0 l\u2019utilisation du plasma congel\u00e9. Journal Officiel, 23\u00a0juillet 2011, texte 18."},{"key":"10.1016\/j.tracli.2013.02.005_bib0020","unstructured":"Recommandations de l\u2019ANSM sur le plasma th\u00e9rapeutique, juin 2012. http:\/\/ansm.sante.fr\/S-informer\/Points-d-information-Points-d information\/Transfusion-de-plasma-therapeutique-Produits-indications-Actualisation-2012-des-recommandations- Point-d-info."},{"key":"10.1016\/j.tracli.2013.02.005_bib0025","unstructured":"D\u00e9cision du 20\u00a0octobre 2010\u00a0fixant la liste et les caract\u00e9ristiques des produits sanguins labile. Journal Officiel, 28\u00a0novembre 2010, texte 12."},{"key":"10.1016\/j.tracli.2013.02.005_bib0030","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1423-0410.2010.01374.x","article-title":"A comparison of methods of pathogen inactivation of FFP","volume":"100","author":"Rock","year":"2011","journal-title":"Vox Sang"},{"key":"10.1016\/j.tracli.2013.02.005_bib0035","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.transci.2010.09.005","article-title":"Non-infectious serious hazards in plasma transfusion","volume":"43","author":"Sachs","year":"2010","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.tracli.2013.02.005_bib0040","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1423-0410.2009.01167.x","article-title":"Post-transfusion mortality among recipients of ABO-compatible but non-identical plasma","volume":"96","author":"Shanwell","year":"2009","journal-title":"Vox Sang"},{"key":"10.1016\/j.tracli.2013.02.005_bib0045","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1001\/archsurg.2010.175","article-title":"Impact of ABO-Identical vs ABO-compatible non identical plasma transfusion in trauma patients","volume":"145","author":"Inaba","year":"2010","journal-title":"Arch Surg"},{"key":"10.1016\/j.tracli.2013.02.005_bib0050","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1423-0410.2012.01592.x","article-title":"ABO identical versus ABO compatible plasma transfusions","volume":"103","author":"Taraldsrud","year":"2012","journal-title":"Vox Sang"},{"key":"10.1016\/j.tracli.2013.02.005_bib0055","unstructured":"Arr\u00eat\u00e9 du 30\u00a0d\u00e9cembre 1992\u00a0interdisant la d\u00e9livrance d\u2019un produit sanguin humain \u00e0 usage th\u00e9rapeutique. Journal Officiel, NOR: SANP9203357A."},{"key":"10.1016\/j.tracli.2013.02.005_bib0060","unstructured":"The collection, testing and use of blood and blood components in Europe. 2008\u00a0Report. Directorate for the Quality of Medicines and HealthCare of the Council of Europe (EDQM). Council of Europe, May 2011."},{"key":"10.1016\/j.tracli.2013.02.005_bib0065","unstructured":"Report of the US Department of Health and Human Services. The 2009\u00a0national blood collection and utilization survey report 2011. Washington, DC: US Department of Health and Human Services."},{"key":"10.1016\/j.tracli.2013.02.005_bib0070","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000323552","article-title":"The use of solvent\/detergent treatment in pathogen reduction of plasma","volume":"38","author":"Hellstern","year":"2011","journal-title":"Transfus Med Hemother"},{"key":"10.1016\/j.tracli.2013.02.005_bib0075","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/1098-1101(2000)15:3<169::AID-JCA2>3.0.CO;2-R","article-title":"Study of three patients with thrombotic thrombocytopenic purpura exchanged with solvent\/detergent-treated plasma: is its decreased protein S activity clinically related to their development of deep venous thromboses","volume":"15","author":"Flamholz","year":"2000","journal-title":"J Clin Apher"},{"key":"10.1016\/j.tracli.2013.02.005_bib0080","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1046\/j.1537-2995.1999.39111227.x","article-title":"A randomized trial of solvent\/detergent-treated and standard fresh-frozen plasma in the coagulopathy of liver disease and liver transplantation","volume":"39","author":"Williamson","year":"1999","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2013.02.005_bib0085","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/ALN.0b013e3182608cdd","article-title":"In vitro hemostatic properties of French lyophilized plasma","volume":"117","author":"Martinaud","year":"2012","journal-title":"Anesthesiology"},{"key":"10.1016\/j.tracli.2013.02.005_bib0090","doi-asserted-by":"crossref","DOI":"10.1111\/j.1537-2995.2012.03663.x","article-title":"Adverse effects of plasma transfusion","volume":"52","author":"Pandey","year":"2012","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2013.02.005_bib0095","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1537-2995.2011.03247.x","article-title":"Transfusion-associated circulatory overload after plasma transfusion","volume":"52","author":"Narick","year":"2012","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2013.02.005_bib0100","unstructured":"Rapport d\u2019activit\u00e9 h\u00e9movigilance 2011. Agence national de s\u00e9curit\u00e9 du m\u00e9dicament et des produits de sant\u00e9 (ANSM). Juillet 2012. http:\/\/ansm.sante.fr\/var\/ansm_site\/storage\/original\/application\/94eaed87fcb1d3c9d2187f4945256875.pdf."},{"key":"10.1016\/j.tracli.2013.02.005_bib0105","doi-asserted-by":"crossref","DOI":"10.1111\/vox.12007","article-title":"A regional haemovigilance retrospective study of four types of therapeutic plasma in a ten-year survey period in France","author":"Bost","year":"2013","journal-title":"Vox Sang"},{"key":"10.1016\/j.tracli.2013.02.005_bib0110","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1159\/000330372","article-title":"Transfusion-transmitted bacterial infections - haemovigilance data of German blood establishments (1997\u20132010)","volume":"38","author":"Funk","year":"2011","journal-title":"Transfus Med Hemother"},{"key":"10.1016\/j.tracli.2013.02.005_bib0115","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1423-0410.2011.01562.x","article-title":"Evaluation of the hemostatic potential including thrombin generation of three different therapeutic pathogen-reduced plasmas","volume":"102","author":"Hacquard","year":"2012","journal-title":"Vox Sang"},{"key":"10.1016\/j.tracli.2013.02.005_bib0120","article-title":"Plasma transfusion in liver transplantation: a randomized, double-blind, multicenter clinical comparison of three virally secured plasmas","author":"Bartelmaos","year":"2012","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2013.02.005_bib0125","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1046\/j.1423-0410.2000.7930161.x","article-title":"Evaluation of solvent\/detergent-treated plasma in patients with a prolonged prothrombin time","volume":"79","author":"Lerner","year":"2000","journal-title":"Vox Sang"},{"key":"10.1016\/j.tracli.2013.02.005_bib0130","article-title":"SD plasma in TTP and coagulation factor deficiencies for which no concentrates are available. 25th Congress of the International Society of Blood Transfusion. Oslo, Norway, June 27\u2013July 2, 1998","volume":"74","author":"Horowitz","year":"1998","journal-title":"Vox Sang"},{"key":"10.1016\/j.tracli.2013.02.005_bib0135","article-title":"A randomized trial of solven\/detergent and standard fresh frozen plasma in the treatment of the coagulopathy seen during orthoptopic liver transplantation. 25th Congress of the International Society of Blood Transfusion. Oslo, Norway, June 27\u2013July 2, 1998","volume":"74","author":"Freeman","year":"1998","journal-title":"Vox Sang"},{"key":"10.1016\/j.tracli.2013.02.005_bib0140","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1182\/blood-2004-03-0930","article-title":"Photochemically treated fresh frozen plasma for transfusion of patients with acquired coagulopathy of liver disease","volume":"107","author":"Mintz","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.tracli.2013.02.005_bib0145","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1111\/j.1537-2995.2006.00959.x","article-title":"A randomized, controlled Phase III trial of therapeutic plasma exchange with fresh-frozen plasma (FFP) prepared with amotosalen and ultraviolet A light compared to untreated FFP in thrombotic thrombocytopenic purpura","volume":"46","author":"Mintz","year":"2006","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2013.02.005_bib0150","first-page":"18","article-title":"The good use of plasma. A critical analysis of five international guidelines","volume":"6","author":"Iorio","year":"2008","journal-title":"Blood Transfus"},{"key":"10.1016\/j.tracli.2013.02.005_bib0155","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1365-3148.2009.00928.x","article-title":"A survey of physicians\u2019 reasons to transfuse plasma and platelets in the critically ill: a prospective single-centre cohort study","volume":"19","author":"Vlaar","year":"2009","journal-title":"Transfus Med"},{"key":"10.1016\/j.tracli.2013.02.005_bib0160","first-page":"1539","article-title":"Prospective audit of the use of fresh-frozen plasma, based on Canadian Medical Association transfusion guidelines","volume":"166","author":"Luk","year":"2002","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.tracli.2013.02.005_bib0165","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jpeds.2011.08.013","article-title":"Widespread use of fresh frozen plasma in US children's hospitals despite limited evidence demonstrating a beneficial effect","volume":"160","author":"Puetz","year":"2012","journal-title":"J Pediatr"},{"key":"10.1016\/j.tracli.2013.02.005_bib0170","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1537-2995.2010.02798.x","article-title":"The use of fresh-frozen plasma in England: high levels of inappropriate use in adults and children","volume":"51","author":"Stanworth","year":"2011","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2013.02.005_bib0175","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1365-2141.1987.tb02359.x","article-title":"Clotting factor levels and the risk of diffuse microvascular bleeding in the massively transfused patient","volume":"67","author":"Ciavarella","year":"1987","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tracli.2013.02.005_bib0180","first-page":"360","article-title":"Hemostatic factors and replacement of major blood loss with plasma-poor red cell concentrates","volume":"81","author":"Hiippala","year":"1995","journal-title":"Anesth Analg"},{"key":"10.1016\/j.tracli.2013.02.005_bib0185","doi-asserted-by":"crossref","DOI":"10.1111\/j.1537-2995.2012.03621.x","article-title":"Plasma transfusion for patients with severe hemorrhage: what is the evidence?","volume":"52","author":"Callum","year":"2012","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2013.02.005_bib0190","first-page":"R52","article-title":"Management of bleeding following major trauma: an updated European guideline","volume":"114","author":"Rossaint","year":"2012","journal-title":"Crit Care"},{"key":"10.1016\/j.tracli.2013.02.005_bib0195","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1538-7836.2007.02297.x","article-title":"The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage","volume":"5","author":"Charbit","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.tracli.2013.02.005_bib0200","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1111\/j.1365-2141.2010.08208.x","article-title":"A critical evaluation of cryoprecipitate for replacement of fibrinogen","volume":"149","author":"S\u00f8rensen","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tracli.2013.02.005_bib0205","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1160\/TH08-06-0383","article-title":"Point-of-care versus central laboratory coagulation testing during haemorrhagic surgery. A multicenter study","volume":"101","author":"Toulon","year":"2009","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.tracli.2013.02.005_bib0210","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/ALN.0b013e318264c644","article-title":"A prospective randomized clinical trial of efficacy in coagulopathic cardiac surgery patients","volume":"117","author":"Weber","year":"2012","journal-title":"Anesthesiology"},{"key":"10.1016\/j.tracli.2013.02.005_bib0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tmrv.2011.07.005","article-title":"Principles and practice of thromboelastography in clinical coagulation management and transfusion practice","volume":"26","author":"Bolliger","year":"2012","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.tracli.2013.02.005_bib0220","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1097\/01.TA.0000069184.82147.06","article-title":"Acute traumatic coagulopathy","volume":"54","author":"Brohi","year":"2003","journal-title":"J Trauma Inj Infect Crit Care"},{"key":"10.1016\/j.tracli.2013.02.005_bib0295","article-title":"Meta-analysis of plasma to red blood cell ratios and mortality in massive blood transfusions for trauma","author":"Bhangu","year":"2012","journal-title":"Injury"},{"key":"10.1016\/j.tracli.2013.02.005_bib0230","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1097\/CCM.0b013e31820eb517","article-title":"Survival of trauma patients after massive red blood cell transfusion using a high or low red blood cell to plasma transfusion ratio","volume":"39","author":"Rajasekhar","year":"2011","journal-title":"Crit Care Med"},{"key":"10.1016\/j.tracli.2013.02.005_bib0235","first-page":"S329","article-title":"High ratios of plasma and platelets to packed red blood cells do not affect mortality in nonmassively transfused patients","volume":"71","author":"Sambasivan","year":"2011","journal-title":"J Trauma Inj Infect Crit Care"},{"key":"10.1016\/j.tracli.2013.02.005_bib0240","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/hep.20569","article-title":"Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests","volume":"41","author":"Tripodi","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.tracli.2013.02.005_bib0245","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1111\/j.1537-2995.2005.00546.x","article-title":"Paucity of studies to support that abnormal coagulation test results predict bleeding in the setting of invasive procedures: an evidence-based review","volume":"45","author":"Segal","year":"2005","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2013.02.005_bib0300","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1097\/TP.0b013e318250fc25","article-title":"Transfusion rate for 500\u00a0consecutive liver transplantations: experience of one liver transplantation center","volume":"93","author":"Massicotte","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.tracli.2013.02.005_bib0255","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1365-2141.2004.04973.x","article-title":"Is fresh frozen plasma clinically effective? A systematic review of randomized controlled trials","volume":"26","author":"Stanworth","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tracli.2013.02.005_bib0260","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1111\/j.1537-2995.2011.03515.x","article-title":"Is fresh-frozen plasma clinically effective? An update of a systematic review of randomized controlled trials","volume":"52","author":"Yang","year":"2012","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2013.02.005_bib0265","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/ALN.0b013e3182715d4d","article-title":"Effects of fibrinogen concentrate as first-line therapy during major aortic replacement surgery: a randomized, placebo-controlled trial","volume":"118","author":"Rahe-Meyer","year":"2013","journal-title":"Anesthesiology"},{"key":"10.1016\/j.tracli.2013.02.005_bib0270","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJM199108083250604","article-title":"Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura","volume":"325","author":"Rock","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tracli.2013.02.005_bib0275","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1001\/archinte.163.20.2469","article-title":"Comparison of oral vs intravenous phytonadione (vitamin K1) in patients with excessive anticoagulation: a prospective randomized controlled study","volume":"163","author":"Lubetsky","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.tracli.2013.02.005_bib0280","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1423-0410.2010.01339.x","article-title":"Comparison of fresh frozen plasma and prothrombin complex concentrate for the reversal of oral anticoagulants in patients undergoing cardiopulmonary bypass surgery: a randomized study","volume":"99","author":"Demeyere","year":"2010","journal-title":"Vox Sang"},{"key":"10.1016\/j.tracli.2013.02.005_bib0285","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1365-2516.2009.02138.x","article-title":"Successful management of fresh-frozen plasma transfusion therapy based upon clinical symptoms for total knee arthroplasty in a patient with severe factor V deficiency","volume":"16","author":"Rideau","year":"2010","journal-title":"Haemophilia"},{"key":"10.1016\/j.tracli.2013.02.005_bib0290","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1111\/j.1537-2995.2005.00216.x","article-title":"Fresh frozen plasma prepared with amotosalen HCl (S-59) photochemical pathogen inactivation: transfusion of patients with congenital coagulation factor deficiencies","volume":"45","author":"de Alarcon","year":"2005","journal-title":"Transfusion"}],"container-title":["Transfusion Clinique et Biologique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1246782013000116?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1246782013000116?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:34:11Z","timestamp":1761129251000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1246782013000116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":58,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S1246782013000116"],"URL":"https:\/\/doi.org\/10.1016\/j.tracli.2013.02.005","relation":{},"ISSN":["1246-7820"],"issn-type":[{"value":"1246-7820","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transfusion de plasma\u00a0: produits\u2013indications","name":"articletitle","label":"Article Title"},{"value":"Transfusion Clinique et Biologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tracli.2013.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}